Log in to search using one of your social media accounts:

 

Fremanezumab Linked to Fewer Monthly Migraine Days
WEDNESDAY, May 16, 2018 -- For patients with episodic migraine, fremanezumab is associated with a reduction in the mean number of monthly migraine days, according to a study published in the May 15 issue of the Journal of the American Medical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 16, 2018 Category: Pharmaceuticals Source Type: news

Fetal Growth, Maternal Anger Impact Infant Regulation
WEDNESDAY, May 16, 2018 -- Poor prenatal growth and higher postnatal anger have indirect effects on infant reactivity and regulation (RR), according to a study published in the March/April issue of Child Development. Pamela Schuetze, Ph.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 16, 2018 Category: Pharmaceuticals Source Type: news

Best Practices Developed for Use of EHR to Enhance Patient Care
WEDNESDAY, May 16, 2018 -- Best practices have been developed for using electronic health records (EHRs) to enhance patient-centered care, according to an article published online in Medical Economics. During the recent American College of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 16, 2018 Category: Pharmaceuticals Source Type: news

North Carolina joins 5 other states in suing the maker of OxyContin
North Carolina has joined five other states in filing lawsuits against Purdue Pharma, accusing the drug company of igniting the nation ’s opioid crisis by using deceptive marketing practices to sell its painkillers. In marketing its drugs, Purdue Pharma used messages to downplay concerns about addiction and to discredit non-opioid pain relievers, while also pushing for higher doses for its opioid medication and targeting vulner able populations, such as veterans and seniors, N.C. Attorney General… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 16, 2018 Category: Biotechnology Authors: Jessica Seaman Source Type: news

Startup aims to give castoff Vertex drug new life as Alzheimer ’s treatment
In 2001, Vertex Pharmaceuticals announced that it was halting development of a rheumatoid arthritis drug. The treatment, which was designed to block a certain enzyme linked to inflammation, had showed promise in clinical trials, but animal studies turned up worrying side effects of the central nervous system. The drug, a small molecule with the generic name neflamapimod, was largely forgotten until a tiny Cambridge startup called EIP Pharma licensed the rights to it from Vertex in 2014. Led by a… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 16, 2018 Category: Health Management Authors: Max Stendahl Source Type: news

Startup aims to give castoff Vertex drug new life as Alzheimer ’s treatment
In 2001, Vertex Pharmaceuticals announced that it was halting development of a rheumatoid arthritis drug. The treatment, which was designed to block a certain enzyme linked to inflammation, had showed promise in clinical trials, but animal studies turned up worrying side effects of the central nervous system. The drug, a small molecule with the generic name neflamapimod, was largely forgotten until a tiny Cambridge startup called EIP Pharma licensed the rights to it from Vertex in 2014. Led by a… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 16, 2018 Category: Biotechnology Authors: Max Stendahl Source Type: news

YouTube begins banning video channels for talking about CBD oil; claims CBD oil "poses risk of serious physical harm or death"
(Natural News) Jumping in bed with Big Pharma and the corrupt cancer industry, YouTube has begun banning entire video channels that post videos describing the compassionate use of CBD oil in cancer patients. In addition to re-banning the Health Ranger video channel over a video that called for racial unity and peace in our world... (Source: NaturalNews.com)
Source: NaturalNews.com - May 16, 2018 Category: Consumer Health News Source Type: news

Big Opportunities In Europe's Cannabis Market Come With Big Risks
The prospect of a legal European cannabis market is alluring, and those businesses able to capitalize on the opportunity will become some of the largest cannabis companies in the world. However, U.S. and Canadian operators eyeing the market will discover that entering Europe poses unique challenges. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 16, 2018 Category: Pharmaceuticals Authors: Kris Krane, Contributor Source Type: news

Stroke prevention drug combo shows promise
If you've had a minor stroke or a transient ischemic stroke (TIA), taking the clot-preventing drug clopidogrel along with aspirin may lower your risk of having a major stroke within the next 90 days, according to new research published in The New England Journal of Medicine. (Source: World Pharma News)
Source: World Pharma News - May 16, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

How companies can support their employees who provide long-term care to family members
With frequent business travel and two young children at home, Scott Kreiling ’s life was full. And the president of Regence BlueShield of Idaho was about to get busier.  His father had spent years caring for his mother in their Tucson, Arizona, home as she progressed through Alzheimer’s disease. Eventually, Kreiling was able to convince his parents to move to Boise, Id aho, to be closer to him.  “They didn’t want to be a burden to anyone. They wanted to maintain their independence,” Kreiling… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 16, 2018 Category: Pharmaceuticals Authors: Katy Smith Source Type: news

Health Highlights: May 16, 2018
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: 6 States Sue Opioid Maker Purdue, Claiming Company Helped Spur Overdoses Opioid maker Purdue Pharma is the object of lawsuits filed on Tuesday... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 16, 2018 Category: General Medicine Source Type: news

Novo Nordisk increases commitment to stem cell-based therapies
Novo Nordisk today announced an increased commitment to stem cell-based therapies and an expansion of the focus on type 1 diabetes into other serious chronic diseases. This has been made possible through an exclusive collaboration with the University of California San Francisco (UCSF) in which a first milestone in the development of human embryonic stem cell lines has been reached. (Source: World Pharma News)
Source: World Pharma News - May 16, 2018 Category: Pharmaceuticals Tags: Featured Novo Nordisk Business and Industry Source Type: news

Top Novartis lawyer quits after payments to Trump aide
Felix Ehrat to ‘take personal responsibility’ for agreement with Michael Cohen (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 16, 2018 Category: Pharmaceuticals Source Type: news

Rare Caregiving in America: Policy Briefings on First-of-its-Kind...
National Alliance for Caregiving and Global Genes to Host Capitol Hill Briefings on May 17(PRWeb May 16, 2018)Read the full story at http://www.prweb.com/releases/2018/05/prweb15492742.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 16, 2018 Category: Pharmaceuticals Source Type: news

Hornet Gay Social Network Partners with Planned Parenthood and Los...
Hornet is committed to giving its users communication and relationship tools and skills to have healthy relationships as well as provide resources to sexual assault survivors.(PRWeb May 16, 2018)Read the full story at http://www.prweb.com/releases/2018/05/prweb15492412.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 16, 2018 Category: Pharmaceuticals Source Type: news

Queens Medical Associates to Hold Inaugural Clinical Trials Day on May...
Leading oncology and hematology practice educates public on importance of clinical trials, patient opportunities and advances in cancer treatment(PRWeb May 16, 2018)Read the full story at http://www.prweb.com/releases/2018/05/prweb15492065.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 16, 2018 Category: Pharmaceuticals Source Type: news

HEALTHCAREfirst Announces Interface with HospiceRx to Streamline...
Bi-directional interface streamlines pharmacy orders to save time and better accommodate patient needs.(PRWeb May 16, 2018)Read the full story at http://www.prweb.com/releases/2018/05/prweb15489034.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 16, 2018 Category: Pharmaceuticals Source Type: news

NIH Awards BellBrook Labs Phase II Grant to Develop HTS Assays...
The National Institutes of General Medical Sciences (NIGMS) recently awarded BellBrook Labs a $1 million phase II Small Business Innovative Research (SBIR) grant to develop new assays to detect cyclic...(PRWeb May 16, 2018)Read the full story at http://www.prweb.com/releases/2018/05/prweb15487829.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 16, 2018 Category: Pharmaceuticals Source Type: news

Former Head of Janet, Jenner & Suggs Mass Tort Practice Opens...
Nationally recognized plaintiffs' attorney, Robert K. Jenner, launches boutique litigation firm(PRWeb May 16, 2018)Read the full story at http://www.prweb.com/releases/2018/05/prweb15471354.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 16, 2018 Category: Pharmaceuticals Source Type: news

ASGCT Opens Group's Largest-Ever Annual Meeting
The 21st Annual Meeting of the American Society of Gene and Cell Therapy, the first in Chicago and the largest in ASGCT, opens today to more than 3,100 pre-registered attendees to take in nearly 1,000...(PRWeb May 16, 2018)Read the full story at http://www.prweb.com/releases/2018/05/prweb15483882.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 16, 2018 Category: Pharmaceuticals Source Type: news

Yong Fan, MD, Former FDA Senior Product Quality Reviewer, Office of...
NDA Partners Chairman Carl Peck, MD announced today that Yong Fan, MD, former Senior Product Quality Reviewer in the FDA Office of Tissues and Advanced Therapies (OTAT) at the Center for Biologics...(PRWeb May 16, 2018)Read the full story at http://www.prweb.com/releases/2018/05/prweb15487501.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 16, 2018 Category: Pharmaceuticals Source Type: news

Glenmark Pharma launches generic version of asthma drug in Denmark
The product was developed by Celon Pharma and Glenmark has marketing and distribution rights for the product across 15 European countries. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 16, 2018 Category: Pharmaceuticals Source Type: news

New York May Finally Address Its Cannabis Catastrophe By Curbing Arrests
After decades of advocacy and many millions of life-altering arrests, Big Apple residents may soon see change in how marijuana is treated in the nation's consumption capital. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 15, 2018 Category: Pharmaceuticals Authors: Janet Burns, Women at Forbes Source Type: news

New York May Finally Address Its Cannabis-Arrest Catastrophe
After decades of advocacy and many millions of life-altering arrests, Big Apple residents may soon see change in how marijuana is treated in the nation's consumption capital. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 15, 2018 Category: Pharmaceuticals Authors: Janet Burns, Women at Forbes Source Type: news

New York City May Finally Address Its Cannabis-Arrest Catastrophe
After decades of advocacy and many millions of life-altering arrests, Big Apple residents may soon see change in how marijuana is treated in the nation's consumption capital. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 15, 2018 Category: Pharmaceuticals Authors: Janet Burns, Women at Forbes Source Type: news

Star Kleiner Perkins VC may be launching her own firm
One of Kleiner Perkins Caufield& Byers' most successful venture investors is reportedly stepping away from the storied venture firm to launch one of her own. Dr. Beth Seidenberg has been on Forbes Midas List of top investors for the past eight years as the only life science-focused partner at the firm. But Recode cited unnamed sources Monday night who said she is raising funds to start a firm in Los Angeles and will step down from her day-to-day role a t Kleiner Perkins. Seidenberg's departure… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 15, 2018 Category: Pharmaceuticals Authors: Cromwell Schubarth Source Type: news

U.S. state lawsuits against Purdue Pharma over opioid epidemic mount
NEW YORK (Reuters) - Litigation against OxyContin maker Purdue Pharma LP is intensifying as six more U.S. states on Tuesday announced lawsuits, accusing the company of fueling a national opioid epidemic by deceptively marketing its prescription painkillers to generate billions of dollars in sales. (Source: Reuters: Health)
Source: Reuters: Health - May 15, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

FDA: Pharma'On Notice' for Blocking Generics
(MedPage Today) -- Agency aims to increase product competition (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - May 15, 2018 Category: American Health Source Type: news

Some Oregonians may face 16% health insurance hikes in 2019
Oregon health insurers ’ rate requests for next year are all over the map, but considerably less than proposals in at least two other states. In the individual market, the average requests range from a 9.6 percent decrease from PacificSource Health Plans to a 16.3 percent increase from Health Net Health Plan of Oregon, according to data from the Oregon Department of Consumer and Business Services. Those requests would translate to $425 a month for a healthy 40-year-old in Portland who buys a PacificSource… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 15, 2018 Category: Pharmaceuticals Authors: Elizabeth Hayes Source Type: news

Exclusive: These Bay Area health tech startups pulled in the most funding last year
In many ways 2017 was a banner year for the health tech industry, with investment in the sector hitting an all-time-high. Since 2014, when health investment doubled to $4.4 billion, both deal flow and investment dollars have remained strong and continued a largely upward climb. For 2017, venture capital funding approached $6 billion, and the number of $100 million-plus funding deals also broke records, according to d igital health research and investment firm Rock Health. Among Bay Area health tech… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 15, 2018 Category: Pharmaceuticals Authors: Kevin Truong Source Type: news

Partners HealthCare looking to acquire a second New Hampshire hospital
Massachusetts General Hospital says it's looking at acquiring Exeter Health Resources in New Hampshire as part of a plan to develop a new non-profit system for the Seacoast region. Exeter Health Resources would form a regional non-profit with Wentworth-Douglass, which MGH acquired last year. The new non-profit would be a subsidiary of MGH, and would fall under the umbrella of Partners HealthCare, the biggest heath care chain in the state. The boards of each organization have signed letters of intent… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 15, 2018 Category: Pharmaceuticals Authors: Jessica Bartlett Source Type: news

Pennsylvania To Lead Nation In Medical Marijuana Research
Pennsylvania is dead set on becoming a national leader in cannabis research. Eight medical school have been awarded permission to lead the way. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 15, 2018 Category: Pharmaceuticals Authors: Mike Adams, Contributor Source Type: news

Niagara U. eyes grad degree for nurse practitioners
Plans call for opening the program within the next year, giving the university another way to meet growing needs for community-based health care. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 15, 2018 Category: Pharmaceuticals Authors: Tracey Drury Source Type: news

Here's when and where UCF plans to move its Research Park nursing school
The school plans to build a 150,000-square-foot building in Lake Nona for nursing college (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 15, 2018 Category: Pharmaceuticals Authors: Veronica Brezina Source Type: news

Park Dental CEO on taking a bigger bite out of the Twin Cities market
Park Dental has grown largely through acquisitions, nearly doubling its clinic locations from 23 to 45 from 2012 through last year. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 15, 2018 Category: Pharmaceuticals Authors: Katharine Grayson Source Type: news

Tickets for Legacy chief Dr. George Brown's PBJ Power Breakfast still available
While at Legacy Health, President and CEO Dr. George Brown crafted quite the, well, legacy. Brown, who's appearing May 24 at the Portland Business Journal's Power Breakfast, landed at the Portland health care provider in 2008. He quickly set Legacy on a path toward massive organizational growth and, as it navigated the tricky health care reform waters, operational innovation. Tickets fo r Brown's appearance are available here. Under his watch, Brown expanded the health care company from six to… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 15, 2018 Category: Pharmaceuticals Authors: Andy Giegerich Source Type: news

FDA Approves'Biosimilar' Drug to Treat Certain Types of Anemia
TUESDAY, May 15, 2018 -- Retacrit (epoetin alfa-epbx) has been approved by the U.S. Food and Drug Administration as the first " biosimilar " to the anemia drugs Epogen and Procrit. Epogen and Procrit are approved to treat anemia caused by chronic... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 15, 2018 Category: Pharmaceuticals Source Type: news

Prescription Med Use in Children Down Overall From 1999 to 2014
TUESDAY, May 15, 2018 -- From 1999 to 2014 there was a decrease in prescription medication use overall among children and adolescents, according to a study published in the May 15 issue of the Journal of the American Medical Association. Craig M.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 15, 2018 Category: Pharmaceuticals Source Type: news

Acupuncture Doesn't Up Live Birth Rate for Women Having IVF
TUESDAY, May 15, 2018 -- For women undergoing in vitro fertilization (IVF), acupuncture at the time of ovarian stimulation and embryo transfer is not associated with a significant difference in live birth rate compared with sham acupuncture,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 15, 2018 Category: Pharmaceuticals Source Type: news

Prevalence of Adult E-Cigarette Use Up from 2014 to 2016
TUESDAY, May 15, 2018 -- The prevalence of electronic cigarette (e-cigarette) ever use increased among U.S. adults from 2014 to 2016, according to a research letter published in the May 15 issue of the Journal of the American Medical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 15, 2018 Category: Pharmaceuticals Source Type: news

Dual-Hormone System May Lower Time in Hypoglycemia in T1DM
TUESDAY, May 15, 2018 -- For physically active adults with type 1 diabetes, the addition of glucagon delivery to a closed-loop system using wearable sensors with automated exercise detection is associated with reduced hypoglycemia, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 15, 2018 Category: Pharmaceuticals Source Type: news

U.S. state attorneys general sue Purdue Pharma over opioid epidemic
NEW YORK (Reuters) - Several U.S. state attorneys general on Tuesday announced lawsuits against OxyContin maker Purdue Pharma LP, accusing the company of fueling a national opioid epidemic by deceptively marketing prescription painkillers to generate billions of dollars in sales. (Source: Reuters: Health)
Source: Reuters: Health - May 15, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Rite Aid-Albertsons: We'll Be Top 5 Health, Food And Wellness Player
Rite Aid and Albertsons say their future as a combined company includes ample space in Albertsons ’ many grocery stores to expand health and wellness including Rite Aid’s RediClinics. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 15, 2018 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Tags: NASDAQ:WBA NYSE:UNH NYSE:CVS NYSE:RAD NYSE:HUM Source Type: news

Docs Pen More Opioid Scripts When Pharma Reps Provide Perks Docs Pen More Opioid Scripts When Pharma Reps Provide Perks
Physicians who accept free meals and other small perks from companies that manufacture opioids are more likely to prescribe these drugs to their patients, a new study suggests.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 15, 2018 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Medicinal Chemistry Leaders Drs. Phil Carpino and Mike Genin Form New Chemistry Team at Recursion Pharmaceuticals
SALT LAKE CITY, May 15, 2018 -- (Healthcare Sales & Marketing Network) -- Recursion Pharmaceuticals, a biotechnology company that combines artificial intelligence (AI), experimental biology, and automation to discover drugs at scale, today announced that ... Biopharmaceuticals, Personnel Recursion Pharmaceuticals (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 15, 2018 Category: Pharmaceuticals Source Type: news

BrainQ Technologies Raises $8.8 Million to Treat Neurodisorders With Artificial Intelligence
Financing included Norma Investments, OurCrowd.com, and Qure Ventures JERUSALEM, May 15, 2018 -- (Healthcare Sales & Marketing Network) -- BrainQ, developing Artificial Intelligence (AI) powered technologies to treat neurodisorders in innovative ways, ... Devices, Neurology, Venture Capital BrainQ Technologies (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 15, 2018 Category: Pharmaceuticals Source Type: news

Caliber Imaging and Diagnostics, Inc. Announces FDA 510(k) Clearance for its VIVASCOPE System
BOSTON, May 15, 2018 -- (Healthcare Sales & Marketing Network) -- Caliber Imaging & Diagnostics Inc. (Caliber I.D.) announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) for modifications to its VIVASCOPE® S... Devices, Dermatology, FDA Caliber Imaging & Diagnostics, VIVASCOPE (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 15, 2018 Category: Pharmaceuticals Source Type: news

Amneal Introduces First Generic for Mephyton(R) (Phytonadione) Tablets, 5mg
BRIDGEWATER, N.J., May 15, 2018 -- (Healthcare Sales & Marketing Network) -- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) has launched Phytonadione Tablets, USP, 5 mg, the first AB-rated therapeutic equivalent for Mephyton®. The product is available in ... Biopharmaceuticals, Generics, Product Launch Amneal Pharmaceuticals, Mephyton, Phytonadione (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 15, 2018 Category: Pharmaceuticals Source Type: news

New 340B analysis: Hospitals raking in billions while uncompensated care drops by billions
(Source: The Catalyst)
Source: The Catalyst - May 15, 2018 Category: Pharmaceuticals Tags: Patients 340B hospitals 340B Spotlight Source Type: news

Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing from Flying L Partners
Investment will enable Surface to fund its development programs focused on FDA approval of its ocular disease drug candidates SAN DIEGO, and PLEASANTON, Calif., May 15, 2018 -- (Healthcare Sales & Marketing Network) -- Surface Pharmaceuticals, Inc., an... Biopharmaceuticals, Ophthalmology, Venture Capital Surface Pharmaceuticals, Imprimis Pharmaceuticals (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 15, 2018 Category: Pharmaceuticals Source Type: news